MWNA
TARO

Marshall Wace North America’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Marshall Wace North America’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,402
Closed -$334K – 1679
2018
Q3 		$334K Sell
3,402
-21,223
-86% -$2.3M ﹤0.01% 770
2018
Q2 		$2.85M Buy
24,625
+22,460
+1,037% +$2.47M 0.02% 673
2018
Q1 		$214K Sell
2,165
-79,943
-97% -$8.1M ﹤0.01% 1331
2017
Q4 		$8.6M Buy
+82,108
New +$9.02M 0.05% 420

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Marshall Wace North America's TARO Position: Q4 2018 in Review

Marshall Wace North America sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 3,402 shares — an estimated $334K sold.

Marshall Wace North America first reported a position in TARO in Q4 2017 and held it in 4 quarters. The position peaked at $8.6M in Q4 2017. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

  • Marshall Wace North America reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
  • Marshall Wace North America sold 3,402 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $334K.
  • Marshall Wace North America first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2017 and held it in 4 quarters.
  • Marshall Wace North America's Taro Pharmaceutical Industries Ltd. position peaked at $8.6M in Q4 2017.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on Marshall Wace North America's 13F filing for Q4 2018, filed 14 Feb 2019.